Choose your language:
Facebook
LinkedIn
Twitter
Providing Capital & Management Solutions for Private & Public Companies and Sophisticated Investors

Ross McDowall

BlueMount Capital in the news: “Brave new world: Islamic finance in BD“

International IFN Roadshow Bangladesh-2021 was held recently organised by REDMoney Group. The IFN Roadshow-2021 series opens with Bangladesh, a country that has a promising future in Islamic finance, especially as it launched its first corporate Sukuk in 2020. Bangladesh is on a sprint to aggressive development as the public demand for Islamic finance is rising, which has spurred the robust Islamic banking sector in the nation. Continue reading

BlueMount Capital in the news: “Altech Chemicals finalises $195m green bond offering to fund Malaysian high purity alumina plant”

Altech Chemicals (ASX: ATC) has entered the final stages of a $195 million listed green bond offering to provide additional financing for the construction of a planned $400 million high purity alumina (HPA) plant in Malaysia.

The company has been working with UK structuring agent Bedford Row Capital PLC and Perth-based Bluemount Capital since October to prepare for the offering. Continue reading

BlueMount Capital in the news: “Bangladesh: Could corporate Sukuk take off?” IFN 17th March 2021

“Bangladesh turns 50 this month, and in a fitting celebration, March 2021 also saw the country’s first corporate Sukuk announced: a US$250 million issuance from Deshbandhu Group (DGL) expected to mature in 2028. Following on from the government’s first debut sovereign Sukuk back in December 2020, the move is an encouraging one as the economy gathers steam. But with significant barriers remaining to a conducive issuing environment, can Bangladesh maintain its momentum? LAUREN MCAUGHTRY speaks to the lead arranger of the deal to learn more. Continue reading

The Secret to a Successful IPO

There are many measures of success for initial public offerings (IPOs). First and foremost is completing the deal and raising the intended proceeds. From the perspective of remaining and new shareholders, however, the subsequent short-term trading performance is more often seen as the measure of a good IPO as opposed to a bad one.

For the board and management of the newly listed entity, their measure of success and their reputation will depend on how well the newly listed entity performs in the medium term and delivers on the investment proposition on which new shareholders based their investment decision. Continue reading

Technology and International Stock Exchange Listings for US companies

An IPO is often the most important capital markets and wealth creation event in a corporate life cycle. Unmatched access to capital at a lower cost is a clear benefit in favour of an IPO, along with corporate branding opportunities and a host of other benefits.

Companies consider three things when choosing a listing location—the actual out-of-pocket costs for establishing and maintaining the listing, the effects on valuation and liquidity, and the nonfinancial benefits. Continue reading

Healthcare and International Stock Exchange Listings for US companies

An IPO is often the most important capital markets and wealth creation event in your corporate life cycle. Unmatched access to capital at a lower cost is a clear benefit in favour of an IPO, along with corporate branding opportunities and a host of other benefits.

Your company should consider three things when choosing a listing location—the actual out-of-pocket costs for establishing and maintaining the listing, the effects on valuation and liquidity, and the nonfinancial benefits. (A fuller discussion of the pros and cons of listing on the Australian Securities Exchange (ASX) versus the Nasdaq or NYSE can be found in the second of this series of BlueMount Capital’s articles: “International Stock Exchange Listings for US Companies”.) Continue reading

International Stock Exchange Listing – Alternatives for US companies

In the past five years there has been a marked increase in the number of international companies listing on the Australian Securities Exchange (ASX). Why is this happening? What are the thought processes and market dynamics that attracted these companies to list on the ASX? Where these companies are U.S. based, what were the factors that stimulated them to look outside their home capital markets? Are the experiences of these companies relevant to your own capital raising considerations? Continue reading